%0 Journal Article
%T A Meta-Analysis of the Prognostic and Clinicopathological Significance of circZFR in Human Gastrointestinal Cancers
%A Christian Cedric Bongolo
%A Erick Thokerunga
%A Yu Zhang
%A Jian-Cheng Tu
%J International Journal of Clinical Medicine
%P 134-144
%@ 2158-2882
%D 2024
%I Scientific Research Publishing
%R 10.4236/ijcm.2024.153009
%X <strong>Background:</strong> Studies of gastrointestinal (GIT) cancers have shown that circZFR could be involved in the development and progression of various GIT cancers. However, small sample sizes limit the clinical significance of these studies. Here, a meta-analysis was conducted to ascertain the actual involvement of circZFR in the development and prognosis of GIT cancers. <strong>Methods: </strong>PubMed, Embase, Web of Science, and the Cochrane Library were searched up to December 31, 2023. Hazard ratios (HRs) or odds ratios (ORs) with 95% confidence intervals (CIs) were pooled to evaluate the association between circZFR expression and overall survival (OS). Publication bias was measured using the funnel plot and Egger¡¯s test. <strong>Results:</strong> 10 studies having 659 participants were enrolled for meta-analysis. High circZFR expression was associated with poor OS (HR = 1.4, 95% CI: 1.20, 1.70). High circZFR expression also predicted larger tumor size (OR = 4.38, 95% CI 2.65, 7.25), advanced clinical stage (OR = 5.33, 95% CI 3.10, 9.16), and tendency for distant metastasis (OR = 2.89, 95% CI: 1.62, 5.11), but was not related to age, gender, and histological grade. <strong>Conclusions:</strong> In summary, high circZFR expression was associated with poor OS, larger tumor size, advanced stage cancer and tendency for distant metastasis. These findings suggested that circZFR could be a prognostic marker for GIT cancers.
%K CircZFR
%K Gastrointestinal
%K Prognostic
%K Significance
%K Meta-Analysis
%U http://www.scirp.org/journal/PaperInformation.aspx?PaperID=132105